NSCLC (Non-small Cell Lung Carcinoma) Terminated Phase 1 Trials for Epacadostat (DB11717)

IndicationStatusPhase
DBCOND0103105 (NSCLC (Non-small Cell Lung Carcinoma))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02298153A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110)Treatment